UBS Group’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-131,840
Closed -$4.77M 8078
2019
Q1
$4.77M Sell
131,840
-714,000
-84% -$24.5M ﹤0.01% 2248
2018
Q4
$24.4M Buy
+845,840
New +$36.5M 0.01% 952
2016
Q1
Sell
-130,740
Closed -$3.33M 8019
2015
Q4
$3.33M Sell
130,740
-30,000
-19% -$1.1M ﹤0.01% 2321
2015
Q3
$5.18M Buy
160,740
+38,940
+32% +$1.49M ﹤0.01% 1891
2015
Q2
$6.71M Buy
121,800
+13,940
+13% +$887K ﹤0.01% 1807
2015
Q1
$6.01M Buy
107,860
+4,500
+4% +$283K ﹤0.01% 1909
2014
Q4
$7.17M Buy
+103,360
New +$8.8M 0.01% 1779

Other funds holding OVV

UBS Group's OVV Position: Q1 2026 in Review

UBS Group reduced its Ovintiv (OVV) stake by 8% in Q1 2026, selling an estimated $3.85M and leaving 917,294 shares worth $54.5M. The position accounts for 0.01% of the portfolio, ranked #1560.

UBS Group first reported a position in OVV in Q4 2014 and has held it in 46 quarters since. 610 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • UBS Group held 917,294 shares of Ovintiv worth $54.5M as of Q1 2026.
  • UBS Group sold 79,883 Ovintiv shares in Q1 2026, an estimated $3.85M.
  • Ovintiv made up 0.01% of UBS Group's portfolio in Q1 2026, its #1560 holding.
  • UBS Group first reported a position in Ovintiv in Q4 2014 and has held it in 46 quarters since.
  • 610 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.